Your session is about to expire
← Back to Search
Post-ICU Clinic Follow-Up for Reducing Doctor Burnout
N/A
Recruiting
Led By Jakob McSparron, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-post icu follow-up visit), approximately 14 days post patient's follow-up visit
Awards & highlights
Study Summary
This trial will study how a meeting between ICU patients and their doctor can help trainees professionally, reducing burnout and improving perceptions of critical care.
Who is the study for?
This trial is for healthcare providers who have completed at least one 2-week rotation in the medical ICU at the University of Michigan and cared for a patient enrolled in this study. It's focused on those eligible or referred to Post ICU Longitudinal Survivor Experience (PULSE) clinic follow-up.Check my eligibility
What is being tested?
The trial examines the impact of post-ICU clinic visits between patients and their previous critical care providers on provider burnout and professional fulfillment. The goal is to see if these encounters improve long-term relationships and perceptions of critical care.See study design
What are the potential side effects?
Since this study involves non-medical interventions like meetings and surveys, traditional physical side effects are not applicable. However, there may be emotional or psychological impacts related to revisiting intensive care experiences.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (pre-post icu follow-up visit), approximately 14 days post patient's follow-up visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-post icu follow-up visit), approximately 14 days post patient's follow-up visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in the Burnout Scale
Changes in the Professional Fulfillment Scale
Trial Design
2Treatment groups
Experimental Treatment
Group I: Residents meet ICU patients during follow-up visit (encounter)Experimental Treatment1 Intervention
Residents will be paired according to the patient that were cared.
Group II: Residents in the non-encounter groupExperimental Treatment1 Intervention
Residents will not meet with patients that were in the ICU.
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,798 Previous Clinical Trials
6,378,108 Total Patients Enrolled
Jakob McSparron, MDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
30 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Residents meet ICU patients during follow-up visit (encounter)
- Group 2: Residents in the non-encounter group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals currently being recruited for this trial?
"Clinicaltrials.gov reveals that this medical trial is not presently recruiting patients; the listing was posted on February 1st, 2023 and last updated later in January of the same year. Despite its status, there are still 30 other studies currently enrolling participants."
Answered by AI
Share this study with friends
Copy Link
Messenger